These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 18365858

  • 1. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.
    Climacteric; 2008 Apr; 11(2):155-65. PubMed ID: 18365858
    [Abstract] [Full Text] [Related]

  • 2. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 3. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 4. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 5. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 6. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 15; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 7. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.
    Gynecol Endocrinol; 2004 May 15; 18(5):244-57. PubMed ID: 15346660
    [Abstract] [Full Text] [Related]

  • 8. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    Atherosclerosis; 2007 Jul 15; 193(1):142-50. PubMed ID: 16842799
    [Abstract] [Full Text] [Related]

  • 9. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 15; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 10. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.
    Maturitas; 2006 Mar 20; 53(4):413-23. PubMed ID: 16140483
    [Abstract] [Full Text] [Related]

  • 11. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 20; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 12. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar 20; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 13. Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Guvenal T, Durna A, Erden O, Guvenal F, Cetin M, Cetin A.
    Adv Ther; 2009 Aug 20; 26(8):805-11. PubMed ID: 19672567
    [Abstract] [Full Text] [Related]

  • 14. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 20; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 15. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 16. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H, Kiran G.
    Arch Gynecol Obstet; 2006 Apr 10; 274(1):9-12. PubMed ID: 16369811
    [Abstract] [Full Text] [Related]

  • 17. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 10; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    J Cardiovasc Pharmacol; 2006 Apr 10; 47(4):542-8. PubMed ID: 16680067
    [Abstract] [Full Text] [Related]

  • 19. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 10; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 20. Effect of tibolone and raloxifene on serum markers of apoptosis in postmenopausal women.
    Lambrinoudaki I, Karaflou M, Kaparos G, Alexandrou A, Creatsa M, Aravantinos L, Augoulea A, Kouskouni E.
    Climacteric; 2013 Apr 10; 16(2):258-64. PubMed ID: 22642937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.